¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific immune suppression"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
burst-suppression
µ¹¹ßÆÄ¾ïÁ¦
frequency selective fat suppression technique
Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
motion artifact suppression technique
¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
suppression
1. ¾ïÁ¦, ¾ï¾Ð 2. Á¦°Å 3. ÁøÈ
suppression amblyopia
¾ïÁ¦¾à½Ã
suppression scotoma
¾ïÁ¦¾ÏÁ¡
water suppression
¹°ºÐÀÚ¾ïÁ¦
acquired immune deficiency syndrome
ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
circulating immune complex
¼øÈ¯¸é¿ªº¹ÇÕü
drug-induced immune complex
¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
human rabies immune globulin
»ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
immune
¸é¿ª-
immune adherence
¸é¿ªºÎÂø
immune adherence hemagglutination
¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
immune adherence reaction
¸é¿ªºÎÂø¹ÝÀÀ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
7
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune thrombocytopenic purpura
¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
suppression
¾ïÁ¦
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific gravity
ºñÁß
specific phobia
ƯÁ¤°øÆ÷(Áõ)
specific
ƯÀÌ-, ƯÁ¤-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦
suppression amblyopia
¾ïÁ¦¾à½Ã
burst-suppression
µ¹¹ßÆÄ¾ïÁ¦
central suppression
Á߽ɾïÁ¦
frequency selective fat suppression technique
Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
magnetization transfer suppression
ÀÚ±âÈÀü´Þ¾ïÁ¦
motion artifact suppression technique
¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
suppression mutation
¾ïÁ¦µ¹¿¬º¯ÀÌ
obligatory suppression
ºÒº¯¾ïÁ¦
suppression
¾ïÁ¦
suppression scotoma
¾ïÁ¦¾ÏÁ¡
water suppression
¹°ºÐÀÚ¾ïÁ¦
acquired immune deficiency
ÈÄõ¸é¿ª°áÇÌ
acquired immune deficiency syndrome
ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
ancillary immune system
º¸Á¶¸é¿ª°è
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
anti-suppression exercise
¾ïÁ¦¹æÁöÈÆ·Ã
frequency selective fat suppression technique
Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
glucocorticoid suppression test
´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
phase evolution of fat suppression
À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
phenotypic suppression
Ç¥ÇöÇü ¾ïÁ¦
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
granulocyte-specific antigens
°ú¸³±¸Æ¯ÀÌÇ׿ø
group specific C carbohydrate
±ºÆ¯ÀÌ C´Ù´çü.
group-specific
±ºÆ¯ÀÌÀÇ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
anti-suppression exercise
¾ïÁ¦¹æÁöÈÆ·Ã
burst suppression
°¨Á¤¾ï¾Ð
central suppression
Á߽ɾïÁ¦
deoxyuridine suppression test
µ¥¿Á½Ã¿ì¸®µò¾ïÁ¦½ÃÇè
dexamethasone suppression test
µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
dust suppression
¸ÕÁö¹ß»ý¾ïÁ¦.
facultative suppression
ÀӽþïÁ¦
fat suppression
Áö¹æ ¾ïÁ¦
frequency selective fat suppression technique
Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
glucocorticoid suppression test
´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
magnetization transfer suppression
ÀÚÈ Àü´Þ ¾ïÁ¦
motion artifact suppression technique
¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
obligatory suppression
ºÒº¯¾ïÁ¦
phase evolution of fat suppression
À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½